• Working Hours - Mon - Thu: 8:00 - 17:00; Fri: 8:00 - 14:00
What are you looking for?

Blog

A Nurse’s Commitment: How Compassion is Changing TB Care in Nigeria  

Our Lady of Apostles Hospital, Jos, a Faith-Based Organization (FBO) is one of the private providers providing tuberculosis (TB) and HIV services with support from Leprosy and Tuberculosis Relief Initiative (LTR), a sub-recipient of the Institute of Human Virology Nigeria (IHVN)

With funding support from the Global Fund to Fight HIV, TB and Malaria, the hospital provides tuberculosis services. 

For the hospital, the fight against tuberculosis (TB) is not just clinical, it is deeply personal. At the heart of this effort is Emmanuel James, a registered nurse and TB DOT Officer whose journey into TB care began unexpectedly but has since become a calling.

“I actually wanted to work in the Intensive Care Unit,” Emmanuel recalls with a smile, but because I had taken a basic TB course, I was moved to the TB Unit. “I was told that the unit had never had a nurse with a TB background before.  I have found joy in helping patients get better.”

Over the past four years, Emmanuel has dedicated himself to ensuring that TB patients not only receive treatment but also complete it successfully. His role goes beyond administering medication. He supervises patient care, leads infection prevention efforts, and ensures that both patients and healthcare workers remain safe.

A typical day for Emmanuel is anything but routine. Yet, what stands out most to him are the small victories. “I like it when patients come in and say, ‘I feel better today.’ That means everything,” he says. “Our work is built on empathy. We listen to our patients and help them find solutions that work for them.”

This patient-centered approach is a cornerstone of the success of the Global Fund tuberculosis program in Nigeria. It means that rather than strictly enforcing guidelines, Emmanuel adapts treatment plans to fit individual lifestyles while still staying within medical standards.

“We’re not just book-oriented; we’re patient-centric,” he explains. “If a patient says 6 a.m. works best for their medication, we help them set reminders, so they don’t miss it. When patients feel heard, they are more committed to their treatment.”

One of the biggest challenges his patients face is not the medication itself, but everyday realities like hunger and transportation. “Some patients skip their drugs because it increases their appetite, and they don’t have enough food,” he shares. “Others struggle with transport costs. So before starting treatment, we look at how far they live and try to make things easier for them.”

Despite these challenges, Emmanuel has witnessed remarkable stories of resilience. One case that stands out involved a patient who repeatedly tested positive for TB even after completing treatment. “He was worried because he kept hearing TB is curable, yet he wasn’t getting better,” Emmanuel recounts.

“After further testing, we discovered he had drug-resistant TB. He went through another round of treatment, and today, he’s completely fine. He still checks in to say he’s doing well. That kind of outcome is incredibly fulfilling.”

Beyond physical healing, Emmanuel has also seen how TB treatment can restore lives. He remembers a young woman who faced both illness and rejection from her family. “She was very sick and emotionally broken because her family had abandoned her,” he says. “We worked with her, counseled her, and even tried to reconnect her with her family. It took time, but after about three months, they accepted her again. That was when we truly saw her recover not just physically, but emotionally. Today, she’s doing well in her business and with her family.”

Due to the commitment of health care workers like Emmanuel, the Global Fund Nigeria TB-HIV Reach, Integration and Impact Project (N-THRIP) project has identified more than 237,000 individuals with tuberculosis including 85, 565 children and 3,038 people with drug-resistant tuberculosis between January 2024 and December 2025.

For Emmanuel, success is not measured in numbers but in transformation. “When I see a patient gain weight, stop coughing, and smile again that’s success,” he says. “Even when they come in sad, I want them to leave feeling better.”

Emmanuel’s message to anyone starting TB treatment is simple but powerful: “Take your medication as directed and don’t be afraid. TB is curable. We’re here to support you every step of the way.”

And to the wider community, he emphasizes prevention: “If we all practice basic measures like proper cough etiquette and early testing, we can reduce the spread. Prevention is always better than cure.”

Through compassion, innovation, and unwavering commitment, thousands of health care workers across the country are contributing to the fight against tuberculosis in Nigeria.

IHVN and its sub-recipients like LTR continue to provide support and mentorship to ensure that prevention, treatment and care services for tuberculosis are provided.

Call for Application for Masters Students to conduct Research within the NORA Research Project

Network for Oncology Research in Sub-Saharan Africa (NORA) Call for Application for Masters Students to conduct Research within the NORA Research Project

About the project

Cancer causes an estimated 533,000 deaths in the Sub-Saharan Africa (SSA) annually. Breast cancer and cervical cancer are the most common in the SSA, making women the more disproportionately affected demographic. The biggest challenges to cancer care in this region are the lack of sufficient data, implementation, monitoring, challenges to comprehensive, interdisciplinary, and multi-level cancer care at all levels of the health system. The widely established benchmark indicators of adequate care are screening uptake, stage at presentation, time to diagnosis, and referral to treatment. Applied research aimed at substantially contributing to decreasing mortality must address key variables along the continuum of care such as, what is the pattern of cancer incidence, cancer stage, cancer survival and how does it change over time? How can the demand for cancer screening in rural and urban communities be increased? How can cancer care be successfully integrated in decentral primary care settings? How can hospital-based cancer registries help trace patient journeys and support standardized treatment referral within a resource constrained setting.

The overall goal of the Network for Oncology Research in Africa (NORA) is to contribute to reducing mortality of Breast Cancer and Cervical Cancer in partner countries (Nigeria, South Africa, Ethiopia and Tanzania) that are part of the NORA consortium. NORA is set to carry out research which establishes evidence-based breast cancer, cervical cancer screening, and treatment pathways applicable in SSA. The research also seeks to generate policy recommendations for effective cancer control strategies. Ultimately, the goal of NORA is to contribute to a significant reduction in breast cancer and cervical cancer mortality in Africa.

In addition, NORA provides the following:

  1. A platform for academics and young scientists with comprehensive methodological and management competencies, enabling them to take on long-term applied research within the framework of national strategies.
  2. An advanced mentoring concept which gives scientists confidence to develop their individual research profiles.
  3. Intensive networking and participation in scientific events geared towards fostering a community of practice, aimed at shaping the African research agenda, and adapting it to population needs.

Requirements for selection

The project involves capacity building for scientists in the field of cancer research and is therefore offering opportunities for master’s students in target research themes along the cancer care continuum to develop their research, leadership skills and future independent research careers.

Master Students interested in applying are expected to have:

  1. A first degree in relevant health sciences
  2. Must be newly enrolled (Not more than one month) in a master’s degree program in Nigeria, within the field of epidemiology, public health, or implementation sciences for themes related to public health.
  3. Master’s degree course/research area is closely related with cancer research and willing to conduct research in the following areas as part of master’s dissertation/thesis.
  4. Systematic qualitative review
  5. Community based palliative care
  • Prior Research experience will be an added advantage.
  • Strong interest in scholarly writing and peer-reviewed publication will be an advantage.

Eligibility Criteria:

  1. Language requirement: Fluency in English (written and spoken).
  2. Interest in cancer research and a commitment to a career path in cancer epidemiology and cancer-related research-training.
  3. Enrolled in a Masters training programme in a recognized training institution in Nigeria prior to application (Not more than six months into the second semester, having completed or being in the process of completing their coursework, but yet to finalize a topic for their thesis)
  4. Willingness to centre thesis around the NORA research areas of cancer registration, breast and cervical cancer
  5. Time and willingness to participate in team activities such as data collection, abstract writing, team meeting, scheduled PowerPoint presentations on progress updates and attendance of consortium meetings.
  6. Possess relevant skills/qualities such as punctuality, leadership, teamwork, communication and creativity.

Application process:

 Eligible candidates are required to submit the following:

  1. Updated academic CV with publications (if any) relevant to your application.
  2. Application letter stating reasons for application and why you are eligible for the role.
  3. A Personal statement stating the following:
  4. Description of relevant professional achievements and related experience
  5. Motivation for application
  6. Research interests
  7. Career goals, future growth and career advancement based on this fellowship opportunity.
  1. A 3–5-page research concept with background, hypothesis/research question, objectives, methods and reference.
  2. Also include a summary not exceeding 350 words with introduction/background, objective, method and expected result.
  3. Two academic reference (supporting) letters.

Interested candidates are invited to send application letters and detailed curriculum vitae in Microsoft Word format to the Assistant Director, Human Resources at [email protected].

The application deadline is 20th June 2026. Late applications will not be accepted.

About the employment offer:

The project will provide successful candidates with the following:  

  1. Stipend as per the project scale for successful candidates
  2. Research project support and 50% tuition coverage
  3. Multidisciplinary mentoring and capacity building across the consortium universities and centers 
  4. Possible covering of additional training cost and travel support 

Recruitment

Shortlisted candidates will be invited for an interview by the panel of assessors and interviewers.

Bid Advert | Enhancing the Mobile Application for Tuberculosis Screening (MATS) under GF N-THRIP grant | 1st June 2026

The Institute of Human Virology, Nigeria is seeking bidders to bid for the Enhancing the Mobile Application for Tuberculosis Screening (MATS) under GF N-THRIP grant
Opening Date/ Time:1st June 2026
Closing Date/ Time:15th June 2026 @10:00am
For more on this bid, kindly download the complete bid document,Click here to download the bidding document